These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 32187139)

  • 1. Impact of Routine Rotavirus Vaccination in Germany: Evaluation Five Years After Its Introduction.
    Marquis A; Koch J
    Pediatr Infect Dis J; 2020 Jul; 39(7):e109-e116. PubMed ID: 32187139
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term surveillance of rotavirus vaccination after implementation of a national immunization program in Finland (2008-2018).
    Hemming-Harlo M; Gylling A; Herse F; Haavisto I; Nuutinen M; Pasternack M; Kanibir MN; Hartwig S; Carias C
    Vaccine; 2022 Jun; 40(29):3942-3947. PubMed ID: 35641360
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact and effectiveness of RotaTeq® vaccine based on 3 years of surveillance following introduction of a rotavirus immunization program in Finland.
    Vesikari T; Uhari M; Renko M; Hemming M; Salminen M; Torcel-Pagnon L; Bricout H; Simondon F
    Pediatr Infect Dis J; 2013 Dec; 32(12):1365-73. PubMed ID: 24051998
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modelling the epidemiological impact of rotavirus vaccination in Germany--a Bayesian approach.
    Weidemann F; Dehnert M; Koch J; Wichmann O; Höhle M
    Vaccine; 2014 Sep; 32(40):5250-7. PubMed ID: 25045820
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of rotavirus vaccination on the burden of acute gastroenteritis in Nagoya city, Japan.
    Yoshikawa T; Matsuki T; Sato K; Mizuno M; Shibata M; Hasegawa S; Morita M; Iwasa M; Gopala K; Holl K
    Vaccine; 2018 Jan; 36(4):527-534. PubMed ID: 29248263
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Socioeconomic Impact of the Rotavirus Vaccine in Korea: Comparing the Epidemiologic and Economic Characteristics of Rotavirus Gastroenteritis Before and After the Introduction of Vaccines.
    Cho H; Lee H; Kim DS; Kim HM; Kim JH; Kim AY; Kang HY
    Pediatr Infect Dis J; 2020 May; 39(5):460-465. PubMed ID: 31990891
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Primary care-based surveillance to estimate the proportion of rotavirus gastroenteritis among Latvian children below 5 years of age with acute gastroenteritis.
    Tafalla M; Gardovska D; Gopala K; Kozlovska L
    Hum Vaccin Immunother; 2019; 15(6):1272-1278. PubMed ID: 30335570
    [No Abstract]   [Full Text] [Related]  

  • 8. Impact of five years of rotavirus vaccination in Finland - And the associated cost savings in secondary healthcare.
    Leino T; Baum U; Scott P; Ollgren J; Salo H
    Vaccine; 2017 Oct; 35(42):5611-5617. PubMed ID: 28893475
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rotavirus gastroenteritis hospitalization rates and correlation with rotavirus vaccination coverage in Sicily.
    Restivo V; Caracci F; Sannasardo CE; Scarpitta F; Vella C; Ventura G; Tramuto F; Costantino C
    Acta Biomed; 2018 Oct; 89(3):437-442. PubMed ID: 30333453
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Projected Public Health Impact of a Universal Rotavirus Vaccination Program in France.
    Oluwaseun S; Cagnan L; Xausa I; Nachbar RB; Levy Bachelot L; Chen YH; Carias C
    Pediatr Infect Dis J; 2024 Sep; 43(9):902-908. PubMed ID: 39163534
    [TBL] [Abstract][Full Text] [Related]  

  • 11. First year experience of rotavirus immunisation programme in Finland.
    Leino T; Ollgren J; Salo H; Tiihonen P; Kilpi T
    Vaccine; 2012 Dec; 31(1):176-82. PubMed ID: 23122991
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of the introduction of rotavirus vaccination on paediatric hospital admissions, Lothian, Scotland: a retrospective observational study.
    Forrest R; Jones L; Willocks L; Hardie A; Templeton K
    Arch Dis Child; 2017 Apr; 102(4):323-327. PubMed ID: 27806968
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute gastroenteritis hospitalizations after implementation of universal mass vaccination against rotavirus.
    Kõivumägi K; Toompere K; Soeorg H; Kallas E; Jõgeda EL; Huik K; ; Lutsar I
    Vaccine; 2020 Mar; 38(13):2879-2886. PubMed ID: 32067818
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rapid impact of rotavirus vaccine introduction to the National Immunization plan in southern Israel: comparison between 2 distinct populations.
    Givon-Lavi N; Ben-Shimol S; Cohen R; Greenberg D; Dagan R
    Vaccine; 2015 Apr; 33(16):1934-40. PubMed ID: 25744226
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A review of rotavirus vaccine use in Asia and the Pacific regions: challenges and future prospects.
    Buchy P; Chen J; Zhang XH; Benninghoff B; Lee C; Bibera GL
    Expert Rev Vaccines; 2021 Dec; 20(12):1499-1514. PubMed ID: 33275065
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rotavirus vaccines in Israel: Uptake and impact.
    Muhsen K; Cohen D
    Hum Vaccin Immunother; 2017 Jul; 13(7):1722-1727. PubMed ID: 28281866
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rotavirus gastroenteritis hospitalizations in provinces with different vaccination coverage rates in Spain, 2013-2018.
    Ruiz-Contreras J; Alfayate-Miguelez S; Carazo-Gallego B; Onís E; Díaz-Munilla L; Mendizabal M; Méndez Hernández M; Ferrer-Lorente B; Unsaín-Mancisidor M; Ramos-Amador JT; Croche-Santander B; Centeno Malfaz F; Rodríguez-Suárez J; Cotarelo M; San-Martín M; Arístegui J
    BMC Infect Dis; 2021 Nov; 21(1):1138. PubMed ID: 34742235
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Universal rotavirus vaccination program in Sicily: Reduction in health burden and cost despite low vaccination coverage.
    Costantino C; Restivo V; Tramuto F; Casuccio A; Vitale F
    Hum Vaccin Immunother; 2018; 14(9):2297-2302. PubMed ID: 29757707
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Benefit Versus Risk Assessment of Rotavirus Vaccination in France: A Simulation and Modeling Analysis.
    Ledent E; Arlegui H; Buyse H; Basile P; Karkada N; Praet N; Nachbaur G
    BioDrugs; 2018 Apr; 32(2):139-152. PubMed ID: 29589230
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sustained reduction in rotavirus-coded hospitalizations in children aged <5 years after introduction of self-financed rotavirus vaccines in Japan.
    Kobayashi M; Miyazaki M; Ogawa A; Tatsumi M
    Hum Vaccin Immunother; 2020; 16(1):132-137. PubMed ID: 31298962
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.